Asthma Clinical Trial
Official title:
Improving the Quality of Private Sector Health Care in West Bengal
The rural healthcare market in much of the developing world is composed largely of informal
private providers. These private providers often have little to no certifiable medical
training. Recent studies in India using medical vignettes (or hypothetical medical
situations) to measure clinical competence and direct observations of doctor-patient
interactions to measure clinical practice highlight the poor quality of care that most
patients receive—a problem that is clearly relevant beyond India and affects most low-income
countries worldwide. For instance:
1. In rural India, standardized patients presenting with chest pain and (on further
questioning) radiating pain in the arm are (correctly) diagnosed with a heart attack in
less than 25 percent of cases.
2. Across 8 low and middle-income countries, health care providers completed the four
necessary vital statistics for new patients in less than 4 percent of interactions:
health care providers in the public sectors of many developing countries routinely
spend less than 1 minute per patient.
To address these deplorably low standards in both medical knowledge and practice, the Liver
Foundation in Kolkata has been working with private rural health care providers through
capacity building activities to improve quality in the private sector. The program consists
of multiple-week training to private rural health care providers on the basis of a
well-developed curriculum in the district of Birbhum, West Bengal.
This study aims to assess the impact of this training program using a randomized evaluation,
in which providers are randomly assigned to the treatment, i.e. the Liver Foundation's
training program, or the control, i.e. no such training. As an independent outside
evaluation team, we will run a baseline survey for all providers (through a third party data
collection agency), monitor the application of and compliance in the Liver Foundation's
training intervention, and conduct a final endline study. By comparing the treatment and
control groups on a variety of measures developed to capture competence in provider
knowledge and practice, we can rigorously assess whether such a training program for
informal rural health care providers is an effective means of improving provider medical
knowledge and practice in the short run. It is worth noting that this study will not be able
to capture long run effects , such as price or location changes, on health care for the
rural poor.
The evaluation of the Liver Foundation training program for rural health care providers
consists of four phases. In the first phase, the Liver Foundation will comb blocks in
Birbhum district and invite 300-400 rural health care providers to participate in the
program. In the second phase, all recruited providers will convene at a center in Birbhum
where we, the evaluation team JPAL, will conduct a baseline study. We will then randomly
allocate participating providers into two groups: the Treatment group, which will receive
the Liver Foundation training within the next twelve months, and the Control group, which
will not. In the third phase, the program inductees will be trained according to the
curriculum put forth by the Liver Foundation. Finally, in the fourth phase, we will run an
extensive endline survey to evaluate how training has affected the (1) clinical practice,
(2) clinical competence, and (3) prices charged and caseload of the providers who have
received the training relative to their non-trained counterparts. We detail each phase in
turn.
Phase I: Provider Census in Birbhum District The Liver Foundation will identify between 300
to 400 representative private rural health care providers within the Birbhum district who
are interested in the training program provided by the Liver Foundation and willing to
participate in the necessary randomized selection process. All providers will be told that
if they attend the baseline study, they will receive the medical training; however, how soon
they will receive it will be determined through a lottery.
Phase II: Baseline Study and Randomization of Providers into Training Intervention
Bringing the providers in batches to a center established for this purpose in Birbhum, the
evaluation team will run a baseline study on all 300 participants over the course of three
weeks. The baseline study will consist of two parts:
1. Baseline provider survey: this survey asks basic questions about training,
socioeconomic background, work practices, etc.
2. Vignette testing: Teams of trained vignette testers will test each doctor's competence
through a series of five medical vignettes.
After having completed the above two steps of the baseline survey, the evaluation team will
randomly allocate these providers into two groups: the "Treatment" group, which will receive
the training, and the "Control" group, which will not. Note that those individuals selected
for the control group will be informed that they will receive training at a later time due
to limited resources; thus we will phase them in one year later, after the evaluation of the
first treatment group is complete.
Phase III: Training Intervention The primary objective of the Liver Foundation's training
program will be capacity building through theoretical information in health sciences,
training in proper referral techniques during emergencies, and maternal and child health
care priorities in rural areas. The training will be in the form of two three-hour classes
per week and will continue for nine months, with three mid-term exams administered every
three months as per the Liver Foundation curriculum. During this time, the evaluation team
will only collect the rosters of the attendees of the training classes and conduct sporadic
random visits to the sessions to gain a better sense of the training methods and attendance
rates.
Phase IV: Endline survey After the intervention has run its course for at least nine months,
we will wrap up the evaluation with an extensive endline survey. Unlike the baseline survey,
which can be completed in the one central location at which the providers meet, the endline
survey must be done at each providers' own place of work. We expect that the process of
locating and evaluating each of the 300 providers at his or her place of work will require
approximately three months.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|